• SENSEX 76,543.00
    -871.92 (--1.13%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    530.75 738.65(%)
  • HDFC Bank
    1,784.05 1,430.15(%)
  • Adani Green
    935.00 758.00(%)
  • ICICI Bank
    1,328.95 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • Vodafone Idea
    7.49 19.15(%)
  • Reliance Industr
    1,258.00 1,156.00(%)
  • Infosys
    1,520.00 1,359.10(%)
  • St Bk of India
    782.50 912.10(%)
  • Trent
    5,605.00 8,345.85(%)
  • M & M
    2,727.00 3,276.30(%)
  • Mazagon Dock
    2,605.00 920.48(%)
  • Tata Motors
    666.00 606.20(%)
  • Indian Renewable
    158.85 135.50(%)
  • Nip. India Gold
    76.25 74.79(%)
  • Bajaj Finance
    8,786.00 6,376.55(%)
  • ITC
    408.25 381.24(%)
  • Bharat Electron
    295.55 198.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Tyche Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21199.0
  • ISIN : INE443B01012
133.05 -4 (-2.81%)
  • As on 01 Apr 2025 (EOD)

  • Today’s Low

    131.30

  • Today’s High

    140.00

  • Open

    139.75

  • Perv Close

    136.90

  • 52W Low

    129.10

  • 52W High

    230.00

Key Indicators

  • P/E(TTM)

    10.06

  • Mar.Cap (₹Cr.)

    136.38

  • Div & Yield %

    1.88

  • Book Value(₹)

    130.20

  • Debt-Equity Ratio

    -2.81

  • AGM Date

    28-Mar-2025

  • EPS

    13.23

  • P/E Ratio

    10.06

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    136.38

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.25

  • BV (₹)

    130.20

  • Sales( ₹ in Cr.)

    69.51

  • NP (in Cr.)

    12.24

  • NP Var(%)

    -14.0

  • Div%

    25.0

  • CPS (₹)

    13.80

  • EPS (₹)

    11.90

  • Traded Value (₹ in Lakhs)

    136.38

  • 52 Week High

    230.00

  • 52 Week Low

    129.10

  • Price BSE

    133.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    136.38

  • P/C Ratio

    9.60

  • P/E Ratio

    11.10

  • Price Vs.BV

    11.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 69.51 75.39 62.27 78.24 73.70 53.95
Excise Duty 69.51 75.33 61.99 71.55 68.50 53.95
Net Sales 69.51 75.39 62.27 78.24 73.70 53.95
Other Income 5.92 4.83 4.16 4.74 3.68 2.52
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 75.43 80.21 66.42 82.98 77.38 56.47
EXPENDITURE :
Raw Materials 69.51 75.33 61.99 71.55 68.50 53.95
Power & Fuel Cost 69.51 75.33 61.99 71.55 68.50 53.95
Employee Cost 9.48 9.06 8.05 8.83 7.38 7.17
Other Manufacturing Expenses 0.88 0.88 0.92 0.52 0.72 0.55
Selling & Administrative Expenses 5.38 5.91 5.60 4.64 5.35 4.36
Miscellaneous Expenses 0.88 0.88 0.92 0.52 0.72 0.55
Less : Pre-operative Expenses Capitalised :
Total Expenditure 58.81 61.01 53.09 55.26 54.05 46.62
Operating Profit 11.94 9.79 9.00 12.66 10.14 8.76
Interest 0.00 0.00 0.00 0.01 0.00 0.00
Gross Profit 16.63 19.08 12.64 26.73 23.33 9.85
Depreciation 1.94 1.77 1.79 1.72 1.74 1.84
Profit Before Tax 16.63 19.08 12.64 26.73 23.33 9.85
Tax 4.46 5.03 3.39 6.73 6.03 2.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.07 -0.12 -0.09 0.02 -0.26 -0.28
Reported Net Profit 12.24 14.17 9.33 19.98 17.56 7.15
Extraordinary Items 16.63 19.08 12.64 26.73 23.33 9.85
Adjusted Net Profit 12.24 14.17 9.33 19.98 17.56 7.15
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 2.56 0.00 1.54 1.03 1.03 0.51
P & L Balance carried down 12.24 14.17 9.33 19.98 17.56 7.15
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 25.00 0.00 15.00 10.00 10.00 5.00
Dividend Per Share(Rs) 2.50 0.00 1.50 1.00 1.00 0.50
Earnings Per Share-Unit Curr 11.78 13.74 9.18 19.35 17.14 6.97
Book Value 2.56 0.00 1.54 1.03 1.03 0.51
Book Value(Adj)-Unit Curr 2.56 0.00 1.54 1.03 1.03 0.51

Shareholding Pattern

  • Promoter Group

    61.97%

  • Public Share Holding

    38.03%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,085,641 39.86 4,085,641 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,265,855 22.11 2,265,855 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,351,496 61.97 6,351,496 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 753,569 7.35 753,569 47
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 107,465 1.05 107,465 122
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 18,831 0.18 18,831 41
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 470,703 4.59 470,703 11
Individuals holding nominal share capital up to Rs. 1 lakh 2,358,700 23.01 2,228,987 7,074
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 189,236 1.85 189,236 3
Sub Total 3,898,504 38.03 3,768,791 7,298
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,250,000 100.00 10,120,287 7,308

Company Background

Tyche Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Tyche Industries Ltd
  • BSE Code : 21199.0
  • ISIN : INE443B01012

  • Incorporation Year

    1998

  • Registered Office

    H No C-21/A Road No 9
    Film Nagar Jubilee Hills, Hyderabad,
    Telangana-500096

  • Telephone

    91-40-23541688/23540933

  • FAX

    91-40-23540933

  • Chairman

    G Ganesh Kumar

  • Managing Director

    G Ganesh Kumar

  • Company Secretary

    Pradosh Ranjan Jena.

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    CIL Securities Limited
    214 RaghavaRatna Tow,
    Chiragali Lane,Abids
    Mumbai - Hyderabad 500001

Tyche Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Tyche Industries 133.05 75.43 69.51 10.06 13.41
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92